BioSpace News Archive

Element Biosciences Inc. today announced a partnership with Agilent Technologies demonstrating integration of Element’s AVITI System with Agilent Technologies’ industry-leading SureSelect target enrichment panels, providing customers greater access to these genomic tools.

The oncology radiopharmaceuticals market has been anticipated to grow at a noteworthy speed in the forthcoming years.

The genomic biomarker market has been projected to grow at a noticeable speed in the forthcoming years.

In a recent market study, Fact.MR covers recent developments in the global tricuspid valve repair market, highlighting vital aspects such as trends, drivers, opportunities, and restraints.

Atrial flutter refers to abnormal rhythm of heart. It is marked with atrial rates of around 240 to 400 beats every minute and blockage in the node of atrioventricular.

Honeywell announced a commercial partnership with AstraZeneca to develop and bring to market next-generation respiratory inhalers that use near-zero global warming potential propellants to treat asthma and chronic obstructive pulmonary disease.

The strong momentum continues: first two customer GMP projects signed, full-year gross margin exceeds 2025 target, the rapid growth in orders received and revenue recognized accelerates further, the first clear signs of economics of scale emerges, while the near-term focus shifts to triple our GMP capacity and thereafter being able to run many GMP projects in parallel.

Northern Ireland becomes the first UK region to combine pathology and radiology images and reports in the same medical imaging system.

111, Inc. today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2021 ended December 31, 2021 , before the U.S. market opens on Thursday, March 17, 2022.

Immunovia will participate in the Cowen 42nd Annual Health Care Virtual Conference on March 9, 2022.